1Weiss S W,Goldblum J R. Rhabdomyosarcoma[ M ]//Weiss S W,Goldblum J R. Enzinger and Weiss' s soft tissue tumors. 4th ed. St. Louis : Mosby ,2001:783-835.
2Breitfeld P P, Meyer W H. Rhabdomyosarcoma:new windows of opportunity[J]. Oncologist,2005,10(7) :518-527.
4Dall' Igna P,Bisogno G,Ferrari A, et al. Primary transcrotal excision for paratesticular rhabdomyosarcoma: is hemiscrotectomy really mandatory? [ J ]. Cancer,2003,97 ( 8 ) : 1981-1984.
5Feerari A, Casanova M, Massimino M, et al. The management of paratesticular rhabdomyosarcoma: a single institutional experience with 44 consecutive children [ J]. J Urol, 1998,159 ( 3 ) : 1031-1034.
二级参考文献5
1[1]Hirama T, Koeffler HP. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood, 1995;8:841
2[2]Peter M, Herskowltz I. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell, 1994;79:181
3[3]Serrano M, Hannon GJ, Beach D et al. A new regulatory motif in cell cycle control causing specific inhibition of cyclinD/CDK. Nature, 1993;366:704
4[4]Kamb A, Gruis NA, Jane WF et al. A cell regulator potentially involved in genesis of many tumor types. Science, 1994;264:436
5[5]Wijnaeds LCD, Linden JC, Unnik AJM et al. Histopathological features and grading in rhabdomyosarcoma. Histopathology, 1994;24:303
